Kanes Stephen 4
4 · Sage Therapeutics, Inc. · Filed Oct 21, 2021
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2021-10-19$40.29/sh−1,120$45,125→ 13,471 total - Award
Common Stock
2021-10-19+3,800→ 14,591 total
Footnotes (1)
- [F1]On February 13, 2019, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 9,500 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on October 19, 2021, resulting in the vesting of the PSUs as to 3,800 shares.